Angel et al.;
Monophosphoryl Lipid A protects against Gram-positive sepsis;
Crit. care Med.; 22, Abstract 122, 1994

Baker et al.;
Reduced microvaskular adrenergic receptor activity due to opioids in endotoxin shock;
Circ. Shock; 32, 101 - 112, 1990

Bakker, J., Vincent, J.-L.;
Dobutamine and norepinephrine administration in septic shock patients;
Crit. Care Med.; 22, Abstract 110, 1994

Bellomo, R., Tipping, P., Boyce, N.;
Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients; Crit. Care Med.; 21, 522 - 526, 1993

Boekstegers et al.;
Response to TNF-antibody therapy (MAK 195F) in patients with severe sepsis: comparison to polyvalent IgG therapy; Eur. Cytokine Netw., ,3, 215, 1992

Bone et al.;
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock; N. Eng. J. Med.; 317, 653 - 658, 1987

Bone et al.;
Sepsis syndrome: a valid clinical enity; Crit. Care Med.; 17, 389 - 393, 1989

Bone et al.;
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis; Chest; 101, 1644 - 1655, 1992

Bowton et al.;
Cerebral blood flow is reduced in patients with sepsis syndrome;
Crit. Care Med.; 17, 399 - 403, 1989

Briegel et al.;
Neue Möglichkeiten der therapeutischen Intervention beim septischen Schock; in: Lawin et al. (Hrsg.) Intensivmedizin, Notfallmedizin, Anästhesiologie: Band 81 Intensivmedizin 1992;104 - 118, 1992

Brigham et al.;
Oxygen radicals - an important mediator of sepsis and septic shock;
Klin. Wschr.; 69, 951, 1991

Buchman, T.G.;
Manipulation of stress gene expression: A novel therapy for the treatment of sepsis?;
Crit. Care Med.; 22, 901 - 903, 1994

Conelly et al.;
Serum Ferritin as a predictor of the acute respiratory distress syndrome; Am. J. Respir. Crit. Care Med.; 155, 21 - 23, 1997

Dhainaut et al.;
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical-trial;
Crit. Care Med.; 22, 1720 - 1728, 1994

Dominioni et al.;
Sepsis Score and Complement Factor B for Monitorring Severly Septic Surgical Patients and for Predicting Their Survival; Eur. Surg. Res.; 17, 269 - 280, 1985

Dominioni et al.;
Sepsis score and acute phase protein response as predictors of outcome in septic surgical patients; Arch. Surg.; 122, 141 ff, 1987

Dominioni et al.;
Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater; Arch. Surg.; 126, 236 - 240, 1991

Dressler, Ch., Dauberschmidt, R.;
Der Substitutionseffekt von Humanalbumin bei postoperativen aseptischen und septischen Krankheitsverläufen

Elebute, E.A., Stoner, H. B.;
The grading of sepsis; Br. J. Surg.; 70, 29 - 31, 1983

Fischer, G.W.;
Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies;
J. Clin. Immunol.; 10, Suppl. 40 S - 46 S, 1990

Fischer, C.J.;
Interleukin-1 receptor antagonist (IL-1ra) reduces mortality in patients with sepsis syndrome; American College of Chest Physicians annual meeting, Abstract, San Francisco, 7. November 1991

Forst,H.
Maximierung des O2-Transports beim kritisch Kranken - ein rationales Therapiekonzept ?
Anästhesist; 46, 46 - 52, 1997

Galleano, M., Puntarulo, S.;
Role of antioxidants on the erythrocytes resistance to lipid peroxidation after acute iron overload in rats; Biochemica et Biophysica Cta; 1271, 321 - 326, 1995

Goode et al.;
Free radicals and antioxidants in sepsis; Crit. Care Med.; 21, 1770 - 1776, 1993

Greenman et al.;
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative Sepsis, JAMA; 1266, 1097 - 1102, 1991

Grootendorst et al.;
High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig; Int. Care Med.; 18, 235 - 240, 1992

Grundmann, R., Kipping, N., Wesoly, C.;
Der "Sepsis Score" von Elebute und Stoner zur Definition der postoperativen Sepsis auf der Intensivstation; Intensivmed. und Notfallmed.; 25, 265 ff, 1988

Heering et al.;
Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration; Int. Care Med.; 23, 288 - 296, 1997

Heizmann, W., Lenz, G.;
Rolle der Blutkultur in der Sepsisdiagnostik: Definitionen, Abnahmetechnik und mikrobiologisch-diagnostische Methoden; Anästh. u. Intensivmed.; 6, 176 - 180, 1987

Heller, A., Koch, T.;
Omega-3-Fettsäuren als adjuvante Therapie bei inflammatorischen Reaktionen;
Anästh. u. Intensivmedizin; 10, 517 - 528, 1996

Herbaczyñska-Cedro et al.;
Inhibitory effect of vitamins C and E on the oxygen free radical production in human polymorphonuclear leucocytes; Eur. J. Clin. Invest.; 24, 316 - 319, 1994

Jakob, L.;
Über Allgemeininfektion durch Bacterium coli commune;
Deutsch. Arch. f. klin. Med.; 97, 303 - 347, 1909

Jepsen et al.;
Antioxidant treatment with N-acetylcystein during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study; Crit. Care Med.; 20, 918 - 923, 1992

Kilbourn et al.;
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs;
Crit. Care Med.; 22, 1835 - 1840, 1994

Kreymann, G., Wolf, M.;
Geschichte und Definition der Sepsis - Brauchen wir eine neue Terminologie ?;
Intensivmed.; 32, 185 - 193, 1995

Lee et al.;
Continuous arteriovenous hemofiltration therapy for Staphylococcus Aureus-induced septicemia in immature swine; Crit. Care Med.; 21, 914 - 924, 1993

Lehmkuhl, P., Lips, U., Pichlmayr, I.;
Der Hannover-Intensic-Score (HIS) als neues Klassifikationssystem zur Verlaufskontrolle und Prognosestellung bei Intensivpatienten; Med. Klinik; 12, 235 - 240, 1986

Lehmkuhl, P., Jeck-Thole, S., Pichlmayr, I.;
Score - Systeme zur Kontrolle einer frühzeitigen Immunglobulintherapie bei Intensivpatienten; Intensivmed.; 28, 256 - 261, 1991

Kevy et al.;
Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study;
Int. Care Med.; 23, 282 - 287, 1997

Lin et al.;
Relationship between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis; Crit. Care Med.; 22, 1595 - 1602, 1994

Link, H.;
Inhibition oder Stimulation der Granulozyten bei Sepsis ?; Intensivmed.; 31, 376 - 383, 1994

Lüllvitz et al.;
Intraoperative Volumensubstitution bei großen abdominalchirurgischen Eingriffen unter Berücksichtigung des kolloidosmotischen Druckes (COD); Intensivtherapie; 10, 51 - 60, 1985

Lundsgaard-Hansen, P., Pappova, E.;
Respiratorische Insuffizienz, kolloidosmotischer Druck und Albumintherapie;
Infusionstherapie; 1, 624 - 632, 1974

Martin et al.;
Effect of sepsis on diaphragm blood flow and oxygen delivery;
Crit. Care Med.; 18, Abstract 215, 1990

Martin et al.;
Effects of norepinephrine on right ventricular function in septic shock patients;
Int. Care Med.; 20, 444 - 447, 1994

Matamis et al.;
Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients; Int. Care Med.; 20, 431 - 436, 1994

Meisner et al.;
Procalcitonin (PCT) - ein neuer Parameter zur Diagnose und Verlaufsbeurteilung von bakteriellen Entzündungen und Sepsis; Anästh. u. Intensivmedizin; 10, 529 - 539, 1996

Mira, J.P., Dhainaut, J.F., Brunet, F.;
Platelet activating factor: rationale for the use of PAF-antagonists in sepsis; In: Lamy, M., Thijs, L.G. (eds) Update in Intensive Care and Emergency Medicine 16: Mediators of Sepsis; Springer, Berlin, Heidelberg, Seite 377 - 392, 1992

Moldawer, L. L.;
Biology of proinflammatory cytokines and their antagonists;
Crit. Care Med.; 22, S3 - S7, 1994

Moran et al.;
Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock;
Int. Care Med.; 20, 489 - 495, 1994

Neugebauer et al.;
Mediatorensysteme und Sepsis; Chirurg; 66, 2 - 10, 1995

Piepoli et al.;
Autonomic control of the heart and peripheral vessels in human septic shock;
Int. Care Med.; 21, 112 - 119, 1995

Pittett et al.;
Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients;
Int. Care Med.; 21, 302 - 309, 1995

Rackow et al.;
Increased venous-arterial carbon dioxide tension difference during severe sepsis in rats;
Crit. Care Med.; 22, 121 - 125, 1994

Redl-Wenzl et al.;
Noradrenalin im "High Output-Low Resistance State" beim septischen Abdominalpatienten; Anästhesist; 39, 525 - 529, 1990

Ribeiro et al.;
Sodium arsenite induces heat shock protein-72 kilodalton expression in the lungs and protect rats against sepsis; Crit. Care Med.; 22, 922 - 929, 1994

Roberts et al.;
Effects of prolonged naloxone infusion in septic shock; Lancet; Band 2, 699 - 702, 1988

Schedel et al.;
Treatment of Gram-negative septic shock with an immunoglobulin preparation. A prospective, randomized clinical trial; Crit. Care Med.; 19, 1104 - 1113, 1991

Schoenberg, M. H., Beger, H. G.;
Sauerstoffradikale im septischen Schock; Chirurg; 59, 836 - 841, 1988

Schoenberg et al.;
Sauerstoffradikale und Stickstoffmonoxid in der Sepsis; Chirurg; 66, 18 - 26, 1995

Schricker et al.;
Einfluß intravenöser Zufuhr von Glucose versus Glucose-Xylit (1:1) auf den Kohlenhydrat- und Fettstoffwechsel nach Trauma und während Sepsis;
Infusionsther. Transfusionsmed.; 21, 7 - 13, 1994

Schröder, H.-J., Ottermann, U.;
Gefährdung der Homöostase, des Säure-Basen-, des Wasser-, Elektrolyt- und des Kolloid-Haushaltes durch päroperative orthograde Darmspülung mit physiologischer Kochsalzlösung; Anästhesist; 35, 120, 1986

Schumacker et al.;
Systemic and Gut O2 Extraction during Endotoxemia - Role of Nitric Oxide Synthesis;
Am. J. Respir. Crit. Care Med.; 151, 107 - 115, 1995

Schupp et al.;
The cardiovascular response to incremental doses of dobutamine in septic shock: mechanism of hemodynamic response; Crit. Care Med.; 22, Abstract 108, 1994

Schupp et al.;
The cardiovascular response to incremental doses of dobutamin in septic shock: prediction of survival; Crit. Care Med.; 22, Abstract 109, 1994

Schuster, H. P.;
Sepsis als Ursache des Multiorganversagens: Definition, Pathophysiologie und diagnostische Parameter; Anästh. Intensivther. Notfallmed.; 24, 206 - 211, 1989

Schuster, H. P.;
Therapie des septisch bedingten Multiorganversagens; Internist; 35, 337 - 345, 1994

Seeger, W., Grimminger, F., Walmrath, D.;
Selektive Blockade inflammatorischer Mediatoren als Therapiekonzept in der Sepsis;
medwelt; 44, 664 - 676, 1993

Slutsky et al.;
Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model, Crit. Care Med.; 22, 914 - 921, 1994

Slutsky et al.;
Sodium arsenite induces heat shock protein-72 kilodalton expression in the lungs and protects rats against sepsis; Crit. Care Med.; 22, 922 - 929, 1994

Spies et al.;
Influence of N-acetylcystein on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study;
Crit. Care Med.; 22, 1738 - 1746, 1994

Stein et al.;
Pulmonary edema during volume infusion; Circulation; 52, 888 - 891, 1975

Stadler et al.;
Immunsuppression und Sepsis; Chirurg; 66, 11 - 17, 1995

Stoutenbeck, Chr. P., Saene, H. K. F. van;
Der Darm als zentrales Organ in der Sepsis;
Anästhesiol. Intensivmed. Notfallmed. Schmerzther.; 29, 259 - 263, 1994

Takala, J.;
Splanchnic perfusion in shock; Int. Care Med.; 20, 403 - 404, 1994

The ACCP/SCCM Consensus Conference Comittee:
Definitions for Sepsis and organ failure and guidelines for the use of innovative therapies in sepsis; Chest; 101, 1644 - 1655, 1992

The HA-1A Sepsis Study Group;
Treatment of Gramnegative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin - A randomized, doubleblind, placebo-controlled trial;
N. Eng. J. Med.; 324, 429 - 436, 1991

The XOMA Sepsis Study Group;
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative Sepsis; JAMA; 266, 1097 - 1102, 1991

Thiel, M., Bardenheuer, H.J.;
Medikamentöse Therapie der Sepsis: Eine Indikation für Pentoxyfillin ?;
Anästhesist; 43, 249 - 256, 1994

Thomas, L.;
Labor und Diagnose; 4. Auflage 1992; Medizinische Verlagsgesellschaft mbH

Töns et al.;
Septischer Schock und multiples Organversagen in der chirurgischen Intensivmedizin;
Langenbecks Archiv für Chirurgie; 378, 217 - 232, 1993

Veterans administration systemic sepsis cooperative study group;
Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis; N. Eng. J. Med.; 317, 659 - 665, 1987

Villar et al.;
Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model; Crit. Care Med.; 22, 914 - 921, 1994

von Eschen, K., Ulrich, J.T.;
Maintenance of IL1-Receptor Antagonist (IL-1RA) and cortisol responses in humans rendered endotoxin tolerant by pretreatment with monophosphoryl lipid A (MLA);
Crit. Care Med.; 22, Abstract 117, 1994

Werdan, K.;
Neue Aspekte der Sepsis-Behandlung - Additive Therapiemaßnahmen mit Antikörpern und Antagonisten gegen Bakterientoxine und Sepsismediatoren sowie mit Immunglobulinen;
Intensivmed.; 30, 201 - 217, 1993

Zadrobilek, E.;
Klinik und Therapie des septischen Schocks; Anästhesist, 42, 657 - 671, 1993

Ziegler et al.;
Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin - A randomized, double-blind, placebo-controlled trial;
N. Eng. J. Med.; 324, 429 - 436, 1991